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Abstract - It is well known that antidepressants affect central monoaminergic neurotransmission and that they also modu-
late hormone release in peripheral tissues. Repeated maprotiline (a noradrenaline reuptake inhibitor) and fluoxetine (a 
serotonin reuptake inhibitor) treatment on gene expression of the catecholamine biosynthetic enzymes were examined in 
rat atria and ventricles in vivo. Maprotiline decreased the gene expression of tyrosine hydroxylase (TH) and dopamine-
ß-hydroxylase (DBH) in the rat atrium. Fluoxetine increased gene expression of TH and DBH, but not of phenyletha-
nolamine N-methyltransferase (PNMT). Chronic application of antidepressants did not change the expression of these 
enzymes in the ventricles. We conclude that repeated administration of fluoxetine enhances gene transcription of TH and 
DBH and subsequently stimulates noradrenaline synthesis in rat atria in vivo.
Key words: Antidepressants, catecholamine enzymes, gene expression, atria, ventricles, rats
UDC 612.452:59:577.21
INTRODUCTION
Serotonin and noradrenaline are involved in the 
mechanism of action of most antidepressants. No-
radrenergic and serotonergic antidepressants have 
been associated with somewhat different clinical 
effects. Maprotiline, a noradrenaline reuptake in-
hibitor and fluoxetine, a serotonin reuptake inhib-
itor, are widely used antidepressants. Recently we 
demonstrated that both antidepressants resulted 
in a significant reduction of the symptoms of de-
pression. Long-term maprotiline treatment pro-
duced significant increases in plasma noradrena-
line, while long-term fluoxetine treatment was 
followed by higher levels of noradrenaline and 
adrenaline (Dronjak et al., 2007; Spasojević et al., 
2008). A number of studies have investigated the 
effect of antidepressants on catecholamine biosyn-
thesis. Studies have shown that most of the classi-
cal antidepressants do not stimulate catecholamine 
synthesis. As to the acute effects of tricyclic anti-
depressants on tyrosine hydroxylase (TH) activity, 
chronic treatment with classical antidepressants 
has been found to have little effect or an inhibitory 
effect on the activity and expression of TH in the 
rat brain in vivo (Cambell et al., 1979; Nestler et 
al., 1990; Moret and Briley, 1992). However, Zhu et 
al. (2005) showed that repeated treatment of rats 
with desipramine increased TH mRNA levels in 
the locus coeruleus and amygdala. In contrast, re-
peated administration of fluoxetine decreased TH 
gene expression in the ventral tegmental area and 
substantia nigra (Oliva et al., 2005). These find-
ings indicate that not all types of antidepressants 
produce consistent changes in TH mRNA levels 
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in the brain in response to chronic treatment. 
While these findings suggest that chronic antide-
pressant treatments can alter the synthesis of cat-
echolamines in the brain, no consistent reproduc-
ible effect of these treatments on the biosynthetic 
pathway of catecholamine in peripheral tissues 
have been presented.
The rate-limiting enzyme in the synthesis of cat-
echolamine is TH which catalyzes the conversion of 
tyrosine to dihydroxyphenylalanine (DOPA). DOPA 
is converted to dopamine by a nonspecific enzyme, 
aromatic L-amino acid decarboxylase (AAAD). 
Dopamine is taken up from the cytoplasm into 
storage vesicles and converted into noradrenaline 
by dopamine-ß-hydroxylase (DBH). Noradrenaline 
is then converted to adrenaline by the soluble cy-
toplasmic enzyme phenylethanolamine N-methyl-
transferase (PNMT) (Kvetnansky et al., 2009). In a 
previous study, we found that repeated administra-
tion of fluoxetine enhanced gene transcription of 
TH and DBH in adrenal medulla, whereas mapro-
tiline did not change gene expression of these en-
zymes (Spasojevic et al., 2010). This prompted us 
to investigate the changes in gene transcription of 
catecholamine biosynthetic enzymes in right and 
left atria and ventricles after repeated antidepres-
sants treatment. To estimate the influence of long-
term treatments with noradrenergic and seroton-
ergic reuptake inhibitors on the genes that encode 
the catecholamine biosynthetic enzymes, we com-
pared the effects of maprotiline and fluoxetine on 
the expression of three catecholamine biosynthetic 




Adult Wistar rat males weighing 280-320 g were 
used. The rats were maintained in a temperature-
controlled room (21±1.0 °C) at a 12 h/12 h light/dark 
cycle. Care was taken to minimize the pain and dis-
comfort of the animals that were treated according 
to the recommendations of the Ethical Committee of 
the “Vinča” Institute, Belgrade, which are in accord-
ance with the Guide for Care and Use of Laboratory 
Animals of the National Institute of Health, Bethes-
da, MD, U.S.A.
Drugs and chronic treatment protocols
The rats were randomly divided into three groups. 
The animals received daily injections of the vehicle 
(sterile water), maprotiline (10 mg/kg) or fluox-
etine (10 mg/kg) by the i.p. route. Maprotiline 
(Sigma-Aldrich Chemie, Germany) and fluoxet-
ine (Aeigis LTD, Cyprus) solutions in sterile water 
were sonicated 10 min and were prepared ex tem-
pore. The rats were killed and the right and atrial 
appendage and ventricles were rapidly dissected, 
frozen in liquid nitrogen and stored at -700C until 
use.
Real-time RT-PCR
Total RNAs were isolated using TRIZOL reagent 
(Invitrogen, CA, U.S.A.). Reverse transcription was 
performed employing the Ready-To-Go You-Prime 
First-Strand Bead (AP, Biotech) and pd (N)6 primer 
according to manufacturer’s protocol. Real-Time 
RT-PCR assay was performed exactly as previously 
described (Gavrilović et al., 2008). PCR was per-
formed in the ABI Prism 7000 Sequence Detection 
System at 50oC for 2 min, 95oC for 10 min, followed 
by 40 cycles at 95oC for 15 sec and 60oC for 1 min. A 
reference, endogenous control was included in each 
analysis to correct for the differences in inter-assay 
amplification efficiency, and all transcripts were nor-
malized to cyclophyline A (ID:Rn 00690933) expres-
sion.
Statistical analysis
The results are presented as means ± S.E.M. The 
statistical significance of the differences in gene ex-
pression levels of the examined catecholamine bio-
synthetic enzymes was estimated by the One-way 
ANOVA test. The Tukey post-hoc test was used to 
evaluate the differences between the groups. Statisti-
cal significance was accepted at p<0.05.
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RESULTS
Antidepressant treatments substantially influenced 
the expression of TH only in the atria. Maprotiline re-
duced the expression of this enzyme by 58% (p<0.001) 
in the right atrium. The antidepressant treatment 
had no effect on the level of TH mRNA in the left 
atrium. Fluoxetine, unlike maprotiline, significantly 
increased the relative rate of gene transcription of 
this enzyme in the right atrium by 54% (p<0.05) and 
in the left atrium by 73% (p<0.01). Chronic applica-
tion of antidepressants did not change the expression 
of TH in the ventricles (Fig 1).
One-way ANOVA analysis revealed significant 
antidepressant-induced variations of DBH mRNA 
levels in the atria, but no significant effects in the 
ventricles. Treatment with maprotiline decreased (in 
the right atria by 80%, p<0.0001, and in the left atria 
by 58%, p<0.01), while fluoxetine increased DBH 
mRNA levels (in the right atria by 58%, p<0.001, and 
in the left atria by 39%, p<0.01), similarly to the ef-
fect that they had on the expression of TH (Fig. 2). 
However, chronic application of either maprotiline 
or fluoxetine did not affect PNMT mRNA levels in 
cardiac tissue (Fig. 3).
DISCUSSION
This is the first study to examine the effect of re-
peated antidepressant treatments on the expres-
sion of genes encoding for three catecholamine 
biosynthetic enzymes in the right and left atrial 
appendages and ventricles of the rat in vivo. We 
found that repeated treatment of fluoxetine led to 
an increase in TH and DBH mRNA levels, whereas 
Fig. 1. The effects of chronic treatments with maprotiline and 
fluoxetine on tyrosine hydroxylase (TH) mRNA levels in the 
right and left heart atria and ventricle of adult rat males. The val-
ues are means ± S.E.M. (6-8 rats). Statistical significance: +++ 
p<0.001 placebo vs. maprotiline, * p<0.05, ** p<0.01 placebo vs. 
fluoxetine. 
Fig. 2. The effects of chronic treatments with maprotiline and 
fluoxetine on dopamine-ß-hydroxylase (DBH) mRNA in the 
right and left heart atria and ventricle of adult rat males. The 
values are means ±S.E.M. (6-8 rats). Statistical significance: ++ 
p<0.01, +++ p<0.001  placebo vs. maprotiline, ** p<0.01 placebo 
vs. fluoxetine.
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maprotiline treatment decreased the transcription 
of these enzymes in atria. However, PNMT mRNA 
in the atria remained unchanged after both repeat-
ed maprotiline and fluoxetine treatments. On the 
other hand, in the right and left ventricles, neither 
maprotiline nor fluoxetine had any effect on the 
transcription of genes encoding for either enzyme. 
This result is the first direct evidence for a stimu-
latory effect of fluoxetine and a suppressive effect 
of maprotiline on catecholamine synthesis in the 
atria. The different effects on the regulation of TH 
and DBH in atria during maprotiline and fluoxet-
ine treatment could be due to the different effects 
of the cAMP response element-binding (CREB) on 
gene transcription. Namely, it was confirmed that 
desipramine reduces the phosphorylation of CREB 
on Ser-119, thus inhibiting CRE-dependent gene 
transcription (Schwaninger et al, 1995; Manier et 
al, 2002) including the genes for TH and DBH. 
In contrast, chronic application of SSRI drugs in-
crease the expression of CREB in rat brain (Nibuya 
et al, 1996; Duman, 2004). Interestingly, repeated 
maprotiline and fluoxetine treatments did not af-
fect TH and DBH gene transcription in the right 
and left ventricles. Different modes of regulation 
of the expression of distinct genes have been re-
ported to exist not only in individual organs but 
also within a single organ, e.g. in the heart. Deindl 
et al. (2003) recently reported that lactate dehy-
drogenase-B is upregulated in the right ventricles, 
but downregulated in the left ventricles and atria. 
Also, c-Jun-N-terminal protein kinases (JNKs) are 
elevated in the right ventricles of rats with chronic 
intermittent altitude hypoxia, while their expres-
sion is downregulated in the left ventricles (Strni-
skova et al., 2006). Also, Zhao et al (2002) found 
that many genes are differentially expressed in the 
atria and ventricle. Shinkai et al. (2007) reported 
that the serotonin/noradrenaline reuptake inhibi-
tor milinacipran activates TH through a p44/42 mi-
togen-activated protein kinase (MAPK)-depend-
ent pathway in cultured bovine adrenal medullary 
cells. It is possible that the signaling pathways are 
different in tissues, which could provide a basis for 
selective pharmacologic interventions. Therefore, 
further experiments are required to examine the 
effects of antidepressants on the mechanisms that 
regulate catecholamine biosynthetic enzymes. On 
the other hand, we found that repeated mapro-
tiline and fluoxetine treatments did not change the 
level of PNMT mRNA in all cardiac tissues. Evi-
dence supports the importance of the activation 
of the hypothalamic-pituitary-adrenocortical axis 
in the regulation of PNMT gene expression. Glu-
cocorticoids regulate PNMT at the transcriptional 
and posttranscriptional levels (Wong et al., 1992; 
Tai et al., 2002). We reported previously that long-
term administration of fluoxetine did not increase 
plasma corticosterone, and this might explain un-
changing PNMT mRNA levels.
Further studies are needed to confirm our results 
and to investigate the effect of other antidepressants 
on the synthesis of catecholamines in the peripheral 
sympathoneural system.
Fig. 3. The effects of chronic treatments with maprotiline and 
fluoxetine on phenylethanolamine N-methyltransferase (PNMT) 
mRNA levels in the right and left heart atria and ventricle of 
adult rat males. The values are means ±S.E.M. (6-8 rats). 
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